Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Moving forward. This is an Onc chat board, not a political

<< Previous

Bullboard Posts

Next >>

Comment by Noteableon Aug 14, 2024 10:31am

38 Views

Post# 36178411

RE:RE:RE:RE:RE:RE:Moving forward. This is an Onc chat board, not a political

Perhaps the stockhouse moderator of this message board needs to be petitioned by the majority to remove those who post political messaging here. Action rather than rhetoric will make this happen.

<< Previous

Bullboard Posts

Next >>

Here are three global stocks you should watch